Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Lipid-Protamine-DNA-Mediated Antigen Delivery

Author(s): Dileep P. Vangasseri, Su-Ji Han and Leaf Huang

Volume 2, Issue 4, 2005

Page: [401 - 406] Pages: 6

DOI: 10.2174/156720105774370168

Price: $65

Abstract

The development of novel new generation vaccine systems that is based on proteins, peptides or DNA is of great current interest. However, due to the lower efficiencies of these new generation vaccines, they are seldomly used alone. Rather, their formulations often contain adjuvants, either to enhance the immune responses or to reduce dosing. The present chapter will provide a brief overview of the recent advances in peptide-based cancer vaccine adjuvants, focusing mainly on Liposome-Protamine-DNA (LPD) nanoparticle-mediated antigen delivery.

Keywords: immunogens, cancer vaccines, peptide antigen, mhc molecule, antigen presenting cells (apc), anti-tumor


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy